These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 4121179

  • 21. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ, Van Lier HJ, Reekers P, Koene RA.
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract] [Full Text] [Related]

  • 22. [Liver transplantation in humans].
    Thiel G.
    Schweiz Med Wochenschr; 1970 Jan 31; 100(5):238-9. PubMed ID: 4946439
    [No Abstract] [Full Text] [Related]

  • 23. Clinical renal transplantation.
    Kountz SL.
    Transplant Proc; 1974 Dec 31; 6(4 Suppl 1):99-105. PubMed ID: 4612909
    [No Abstract] [Full Text] [Related]

  • 24. New perspectives on pathogenesis and treatment of rejection in kidney transplantation.
    Merrill JP.
    Kidney Int Suppl; 1975 Feb 31; (3):318-22. PubMed ID: 1099311
    [No Abstract] [Full Text] [Related]

  • 25. Simultaneous homotransplantation of heart and kidney from the same donor in bilaterally nephrectomized dogs.
    Legrain M, Gandjbakhch, Dubois M, Wajcner G, Rottembourg J, Guilmet D.
    Transplant Proc; 1969 Mar 31; 1(1):293-5. PubMed ID: 4944230
    [No Abstract] [Full Text] [Related]

  • 26. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P, Ludwin D, Bear R, Aprile M, McQuarrie B, Poole R, White N.
    Transplant Proc; 1987 Feb 31; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract] [Full Text] [Related]

  • 27. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW, McCoy HV, Phair JP, Altemeier WA.
    Transplant Proc; 1969 Mar 31; 1(1):283-6. PubMed ID: 4944227
    [No Abstract] [Full Text] [Related]

  • 28. Antirejection drugs and procedures.
    Chatterjee SN.
    Am J Surg; 1973 Nov 31; 126(5):678-82. PubMed ID: 4129988
    [No Abstract] [Full Text] [Related]

  • 29. Immunosuppression and clinical organ transplantation.
    Calne RY.
    Transplant Proc; 1974 Dec 31; 6(4 Suppl 1):49-51. PubMed ID: 4612904
    [No Abstract] [Full Text] [Related]

  • 30. Results of the kidney transplantation in the Warsaw Center.
    Nielubowicz J, Orlowski T, Wesolowski S, Falda Z, Gradowska L, Rowińska D, Rowiński W, Skośkiewicz M, Szostek M, Filipowicz Z, Glyda J, Goliszek Z, Jedrzejewski R, Kardasiewicz W, Klepacka J, Klopotowska E, Kossowska B, Koziak H, Krzywicka E, Lao M, Ladygin J, Marzinek B, Miller J, Michalowicz B, Machowski Z, Olszewski K.
    Pol Med J; 1971 Dec 31; 10(2):340-3. PubMed ID: 4104328
    [No Abstract] [Full Text] [Related]

  • 31. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA, Aquino A, Ali A, Rodriguez R, Ali S.
    Transplant Proc; 1987 Feb 31; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract] [Full Text] [Related]

  • 32. Minnesota experience with 81 pancreas transplants since 1978.
    Sutherland DE, Chinn PL, Goetz FC, Elick BA, Najarian JS.
    Transplant Proc; 1984 Jun 31; 16(3):695-703. PubMed ID: 6375036
    [No Abstract] [Full Text] [Related]

  • 33. [Follow-ups after kidney transplantations].
    Halbfass HJ, Staib I, Heinze V, Jontofsohn R, Junkers K.
    Dtsch Med Wochenschr; 1973 Mar 09; 98(10):479-81. PubMed ID: 4570868
    [No Abstract] [Full Text] [Related]

  • 34. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC.
    Urol Clin North Am; 1983 May 09; 10(2):253-62. PubMed ID: 6344386
    [No Abstract] [Full Text] [Related]

  • 35. The role of clinical transplantation in patients with end-stage renal disease.
    Belzer FO, Kountz SL.
    Transplant Proc; 1973 Mar 09; 5(1):793-7. PubMed ID: 4121182
    [No Abstract] [Full Text] [Related]

  • 36. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N, Hong J, Miles A, Markell M, Distant D, Fleishhacker J, Maursky V, Jean-Baptiste F, Sommer B.
    Transplant Proc; 1996 Feb 09; 28(1):356-7. PubMed ID: 8644260
    [No Abstract] [Full Text] [Related]

  • 37. Adjunct antilymphocyte globulin therapy in canine renal allograft recipients: importance of preoperative administration.
    Kelly GE, Drummond M, Sheil AG.
    J Surg Res; 1974 Jun 09; 16(6):620-3. PubMed ID: 4599465
    [No Abstract] [Full Text] [Related]

  • 38. Clinical evaluation of equine antithymocyte globulin in recipients of renal allografts: Analysis of survival, renal function, rejection, histocompatibility, and complications.
    Diethelm AG, Aldrete JS, Shaw JF, Cobbs CG, Hartley MW, Sterling WA, Morgan JM.
    Ann Surg; 1974 Jul 09; 180(1):20-8. PubMed ID: 4599406
    [Abstract] [Full Text] [Related]

  • 39. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC, Sibley RK, Fryd DS.
    Transplant Proc; 1987 Feb 09; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract] [Full Text] [Related]

  • 40. Purified Roswell Park cultured antilymphocytic globulin RPMI-CALG: preparation and clinical trial.
    Moore GE, Murphy GP, Papermaster BW, Amiraian K, Kenny GM, Moore RH.
    J Surg Oncol; 1969 Feb 09; 1(2):153-66. PubMed ID: 4939634
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.